Senate Considers Revised Comparative Effectiveness Plan In Reform Bill
Executive Summary
Comparative effectiveness research led by a non-government institute with funding from public and private sources, as envisioned by Sen. Max Baucus, D-Mont., is among the provisions for health care reform that are being debated by the Senate, but some changes to CER provisions were made as the bill moved from the Finance Committee to its current iteration on the Senate floor
You may also be interested in...
PCORI In Brief: New Board Member, Funding Opportunities
The Patient-Centered Outcomes Research Institute welcomes UCSF professor Alicia Fernandez to the board, announces pragmatic trials funding opportunity; Senate bids farewell to PCORI champion Max Baucus.
WellPoint Plans CER Guidance, Building On Progress With Outcomes Data
WellPoint believes its discussions with drug manufacturers about patient outcomes have improved in the 18 months since it published technology assessment criteria focusing on that topic. Now it is updating its criteria to include how to submit results from comparative effectiveness research
WellPoint Plans CER Guidance, Building On Progress With Outcomes Data
WellPoint believes its discussions with drug manufacturers about patient outcomes have improved in the 18 months since it published technology assessment criteria focusing on that topic. Now it is updating its criteria to include how to submit results from comparative effectiveness research